Introduction: Trisomy 21 (T21), which causes Down syndrome (DS), is the most common chromosomal aneuploidy in humankind and includes different clinical comorbidities, among which the alteration of the immune system has a heavy impact on patient’s lives. A molecule with an important role in immune response is zinc and it is known that its concentration is significantly lower in children with T21. Different hypotheses were made about this metabolic alteration and one of the reasons might be the overexpression of superoxide dismutase 1 (SOD1) gene, as zinc is part of the SOD1 active enzymatic center. Methods: The aim of our work is to explore if there is a linear correlation between zinc level and immune cell levels measured in a total of 217 blood samples from subjects with T21. Furthermore, transcriptome map analyses were performed using Transcriptome Mapper (TRAM) software to investigate whether a difference in gene expression is detectable between subjects with T21 and euploid control group in tissues and cells involved in the immune response such as lymphoblastoid cells, thymus and white blood cells. Results: Our results have confirmed the literature data stating that the blood zinc level in subjects with T21 is lower compared to the general population; in addition, we report that the T21/control zinc concentration ratio is 2:3, consistent with a chromosomal dosage effect due to the presence of three copies of chromosome 21. The transcriptome map analyses showed an alteration of some gene’s expression which might explain low levels of zinc in the blood. Discussion: Our data suggest that zinc level is not associated with the levels of immunity cells or proteins analyzed themselves and rather the main role of this ion might be played in altering immune cell function.

Ramacieri, G., Locatelli, C., Semprini, M., Pelleri, M.C., Caracausi, M., Piovesan, A., et al. (2024). Zinc metabolism and its role in immunity status in subjects with trisomy 21: chromosomal dosage effect. FRONTIERS IN IMMUNOLOGY, 15, 1-10 [10.3389/fimmu.2024.1362501].

Zinc metabolism and its role in immunity status in subjects with trisomy 21: chromosomal dosage effect

Ramacieri, Giuseppe;Pelleri, Maria Chiara;Caracausi, Maria;Piovesan, Allison;Cicilloni, Michela;Vigna, Marco;Vitale, Lorenza;Sperti, Giacomo;Corvaglia, Luigi Tommaso;Pirazzoli, Gian Luca;Strippoli, Pierluigi;Catapano, Francesca
;
Vione, Beatrice;Antonaros, Francesca
2024

Abstract

Introduction: Trisomy 21 (T21), which causes Down syndrome (DS), is the most common chromosomal aneuploidy in humankind and includes different clinical comorbidities, among which the alteration of the immune system has a heavy impact on patient’s lives. A molecule with an important role in immune response is zinc and it is known that its concentration is significantly lower in children with T21. Different hypotheses were made about this metabolic alteration and one of the reasons might be the overexpression of superoxide dismutase 1 (SOD1) gene, as zinc is part of the SOD1 active enzymatic center. Methods: The aim of our work is to explore if there is a linear correlation between zinc level and immune cell levels measured in a total of 217 blood samples from subjects with T21. Furthermore, transcriptome map analyses were performed using Transcriptome Mapper (TRAM) software to investigate whether a difference in gene expression is detectable between subjects with T21 and euploid control group in tissues and cells involved in the immune response such as lymphoblastoid cells, thymus and white blood cells. Results: Our results have confirmed the literature data stating that the blood zinc level in subjects with T21 is lower compared to the general population; in addition, we report that the T21/control zinc concentration ratio is 2:3, consistent with a chromosomal dosage effect due to the presence of three copies of chromosome 21. The transcriptome map analyses showed an alteration of some gene’s expression which might explain low levels of zinc in the blood. Discussion: Our data suggest that zinc level is not associated with the levels of immunity cells or proteins analyzed themselves and rather the main role of this ion might be played in altering immune cell function.
2024
Ramacieri, G., Locatelli, C., Semprini, M., Pelleri, M.C., Caracausi, M., Piovesan, A., et al. (2024). Zinc metabolism and its role in immunity status in subjects with trisomy 21: chromosomal dosage effect. FRONTIERS IN IMMUNOLOGY, 15, 1-10 [10.3389/fimmu.2024.1362501].
Ramacieri, Giuseppe; Locatelli, Chiara; Semprini, Michela; Pelleri, Maria Chiara; Caracausi, Maria; Piovesan, Allison; Cicilloni, Michela; Vigna, Marc...espandi
File in questo prodotto:
File Dimensione Formato  
fimmu-15-1362501.pdf

accesso aperto

Descrizione: Zinc metabolism and its role in immunity status in subjects with trisomy 21: chromosomal dosage effect
Tipo: Versione (PDF) editoriale
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione 560.41 kB
Formato Adobe PDF
560.41 kB Adobe PDF Visualizza/Apri
file supplementari (2).zip

accesso aperto

Tipo: File Supplementare
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione 204.33 kB
Formato Zip File
204.33 kB Zip File Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/1001513
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact